Geode Capital Management LLC Invests $2.58 Million in Ardent Health Partners, LLC (NYSE:ARDT)

Geode Capital Management LLC bought a new stake in Ardent Health Partners, LLC (NYSE:ARDT - Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 140,436 shares of the company's stock, valued at approximately $2,581,000. Geode Capital Management LLC owned approximately 0.10% of Ardent Health Partners as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of ARDT. Wellington Management Group LLP bought a new position in Ardent Health Partners in the 3rd quarter valued at $28,724,000. Point72 Asset Management L.P. purchased a new position in shares of Ardent Health Partners in the 3rd quarter worth about $27,428,000. Goldentree Asset Management LP bought a new position in Ardent Health Partners during the third quarter valued at about $22,897,000. Allspring Global Investments Holdings LLC purchased a new stake in Ardent Health Partners during the third quarter worth about $13,119,000. Finally, Soros Fund Management LLC bought a new stake in Ardent Health Partners in the third quarter worth about $4,595,000.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on ARDT shares. KeyCorp began coverage on shares of Ardent Health Partners in a research report on Friday, October 11th. They set an "overweight" rating and a $24.00 target price for the company. Leerink Partners raised their target price on Ardent Health Partners from $23.00 to $25.00 and gave the stock an "outperform" rating in a research report on Tuesday, November 12th. JPMorgan Chase & Co. restated a "neutral" rating and issued a $20.00 target price on shares of Ardent Health Partners in a research note on Tuesday, December 17th. Stephens reiterated an "overweight" rating and set a $24.00 price target on shares of Ardent Health Partners in a research note on Thursday, September 19th. Finally, Bank of America cut Ardent Health Partners from a "buy" rating to a "neutral" rating and lowered their price objective for the company from $22.00 to $19.00 in a research note on Wednesday, November 6th. Two analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, Ardent Health Partners currently has a consensus rating of "Buy" and an average target price of $22.00.

Ardent Health Partners Trading Up 0.3 %

ARDT traded up $0.05 on Wednesday, reaching $16.41. The company had a trading volume of 97,685 shares, compared to its average volume of 235,177. Ardent Health Partners, LLC has a 52-week low of $14.57 and a 52-week high of $20.72. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78. The business has a 50 day moving average of $16.66.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.